Background: DJ-1 is a redox-sensitive protein with multiple roles in cell homeostasis, levels of which are altered in patients with mast cell (MC)-related disorders. However, whether DJ-1 can regulate human MC function is unknown. Objective: We sought to investigate the potential role of DJ-1 in the responses of human MCs to antigen stimulation. Methods: DJ-1 was silenced in human CD34
measured after FcεRI engagement. Enzymatic assays, sucrose density gradient centrifugation, immunoprecipitation, dot and Western blotting, and confocal imaging were performed for signaling, cellular localization, and coassociation studies. Results: DJ-1 knockdown substantially reduced mediator release, as well as Lyn kinase and spleen tyrosine kinase activation and signaling through mechanisms that appeared largely unrelated to DJ-1 antioxidant activity. Following FcεRI activation, nonoxidized rather than oxidized DJ-1 translocated to lipid rafts, where it associated with Lyn, an interaction that appeared critical for maximal Lyn activation and initiation of signaling. Using purified recombinant proteins, we demonstrated that DJ-1 directly bound to Lyn but not to other Src kinases, and this interaction was specific for human but not mouse proteins. In addition, DJ-1 reduced Src homology 2 domain-containing phosphatase 2 phosphatase activity by scavenging reactive oxygen species, thus preventing spleen tyrosine kinase dephosphorylation and perpetuating MC signaling. Conclusion: We demonstrate a novel role for DJ-1 in the early activation of Lyn by FcεRI, which is essential for human MC responses and provides the basis for an alternative target in allergic disease therapy. (J Allergy Clin Immunol 2018;142:195-206.)
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Antigen-dependent activation of mast cells (MCs) occurs primarily through FcεRI, the high-affinity receptor for IgE, which causes the release and generation of vasoactive and inflammatory mediators of allergic inflammation. 1, 2 Understanding the mechanisms that control IgE-dependent MC activation is critical to the development of small-molecular-weight inhibitors of MC responses and to understanding aberrant regulation. Currently, it is understood that FcεRI aggregated by antigen coalesces within specialized microdomains of the plasma membrane (lipid rafts), and this causes activation of Src family tyrosine kinases (SFKs), among which Lyn is the most critical for the initial stages of signaling elicitation. 3 Activated Lyn then phosphorylates the b and g chains of FcεRI, which lead, respectively, to recruitment of Lyn and recruitment/activation of spleen tyrosine kinase (Syk), an obligatory step for further propagation and divergence of signaling cascades, leading to release of bioactive mediators. [3] [4] [5] Targeting of these receptor-proximal signaling events is preferable because they are common to all antigen-induced MC responses.
Recently, we demonstrated altered serum levels of DJ-1, an evolutionarily conserved protein reported to protect cells against oxidative damage, in patients with atopic dermatitis, and a biphasic regulation in mastocytosis in which DJ-1 was induced by IL-6 and implicated in expansion of neoplastic MCs. 6, 7 Although DJ-1 is abundantly expressed in human MC lines, 6, 7 it is unknown whether DJ-1 can influence FcεRI-mediated activation of human MCs.
As will be shown, we find that the absence of DJ-1 in human MCs (CD34 1 -derived human mast cells [HuMCs] ) results in marked inhibition of FcεRI-induced degranulation and cytokine and eicosanoid production through mechanisms that appear to be independent of its antioxidant activity. Furthermore, we show a direct interaction of DJ-1 with Lyn in lipid rafts and that this association is required for Lyn activation, initiation of human MC signaling, and functional responses. Interaction with Lyn is specific for nonoxidized rather than oxidized DJ-1 and is unique to the human homologs because such an interaction was not observed between murine DJ-1 and Lyn proteins. Thus our data detail a critical and heretofore unknown function for DJ-1 in human MC responsiveness as a novel activator of Lyn that might be of therapeutic interest in developing strategies to target the MC compartment.
METHODS

Human MC cultures
Primary HuMCs were derived from CD34
1 peripheral blood progenitors isolated from healthy volunteers after informed consent under a protocol (NCT00001756) approved by the Institutional Review Board of the National
Institute of Allergy and Infectious Diseases (National Institutes of Health). HuMCs and the MC line LAD2 developed in the Laboratory of Allergic Diseases (NIAID, NIH) were cultured, as previously described. 8, 9 For activation, HuMCs and LAD2 cells were sensitized overnight with biotinylated IgE (0.1 mg/mL) and washed, and the IgE-bound FcεRI was cross-linked with 100 ng/mL streptavidin.
Knockdown of DJ-1 by short hairpin RNA Viral particles containing nontarget (SHC002) or DJ-1-targeted short hairpin RNAs (shRNAs; TRCN0000004921) in a pLKO1 vector were prepared, as previously described, 10 and used to transduce HuMCs or LAD2 cells. Cells were selected in medium containing 0.2 mg/mL puromycin for 5 days. 10 
Measurement of reactive oxygen species and DJ-1
Reactive oxygen species (ROS) levels were measured with the OxiSelect Intracellular ROS Assay Kit (Cell Biolabs, San Diego, Calif), and DJ-1 in supernatants of stimulated cells was measured by using ELISA, as previously described. 7 Alternatively, DJ-1 and oxidized DJ-1 were detected by means of Western blotting. 7 Src homology 2 domain-containing phosphatase 1 and 2 and in vitro kinase assays Phosphatase activities of Src homology 2 domain-containing phosphatase (SHP) 1 and SHP-2 in immunoprecipitates from streptavidin-stimulated LAD2 cells were measured by using a DuoSet IC Phosphatase Assay (R&D Systems, Minneapolis, Minn). Kinase activities in immunoprecipitates of Lyn, Fyn, Fgr, or Syk from cell lysates were determined by using an ELISA-based Universal Tyrosine Kinase Assay Kit (Gen Way, San Diego, Calif). permeabilized with 0.1% Triton X-100 for 10 minutes. Cells were then incubated for 1 hour with 1% BSA before staining. Confocal images were obtained with a Leica SP5 X confocal laser scanning microscope (Leica Microsystems, Buffalo Grove, Ill).
Statistical analysis
Data were expressed as mean 6 SEM values from 3 or more independent experiments. One-way ANOVA was used to determine statistically significant differences between groups with Prism 6 software (GraphPad Software, San Diego, Calif).
A detailed description of the methods used in this study can be found in the Methods section in this article's Online Repository at www.jacionline.org.
RESULTS
Nonoxidized DJ-1 translocates to the plasma membrane early after FcεRI activation
In examining the role of DJ-1 in HuMCs, we first verified that activation through FcεRI resulted in a rapid increase in intracellular production of ROS, which was maximal by 30 minutes, slowly decreasing thereafter (Fig 1, A) , as previously reported. 12 Total intracellular levels of DJ-1 did not change, but DJ-1 was visibly oxidized by 30 minutes at Cys106, the major residue responsible for its antioxidant function (Fig 1, B, upper panels) . Intracellular DJ-1 oxidation plateaued by 1 hour, coinciding with both DJ-1 secretion into the media and the decrease in intracellular ROS levels (Fig 1, A and B , lower panels). Therefore a significant antioxidant effect of DJ-1 was only apparent 30 minutes to 1 hour after FcεRI activation.
Additionally, within 10 minutes after activation, a portion of DJ-1 localized to the plasma membrane, and this translocation was independent of any significant oxidation in Cys106, as determined by using Western blot analysis and confocal microscopy (Fig 1, B and C) . In fact, oxidized DJ-1 appeared distinctly excluded from the plasma membrane at this time point. The redistribution of nonoxidized DJ-1 into the membrane was transient because after 1 hour, most of the total cellular DJ-1 had been oxidized and appeared in the cytosol or associated with organelles (Fig 1, B and C) . By 4 hours, oxidized DJ-1 moved to the plasma membrane, coinciding with secretion of DJ-1 into the extracellular media (Fig 1, A) . Thus DJ-1 secretion appears to be dissociated from degranulation, which is completed within minutes of activation. Because the oxidized form of DJ-1 is preferentially secreted, 13 the late-appearing membrane-localized and now oxidized DJ-1 might well represent molecules in transit to the extracellular space. Of note, amounts of DJ-1 secreted into the media were only a fraction of the cellular DJ-1 content, as indicated in the legend to at www.jacionline.org). Overall, these data indicate that the distinct rapid and transient translocation of nonoxidized DJ-1 to the plasma membrane is unrelated to its scavenger function and might have functional consequences.
DJ-1 is essential for HuMC responses through mechanisms greatly independent of its antioxidant activity
After demonstrating early translocation of DJ-1 to the plasma membrane, we explored whether loss of DJ-1 through shRNA knockdown would have an effect on FcεRI-induced responses. We found that DJ-1 silencing with lentivirus-mediated shRNA resulted in a greater than 75% reduction in DJ-1 (Fig 2, A , and see Fig E2, A and B, in this article's Online Repository at www. jacionline.org) without affecting KIT and FcεRI expression (see Fig E2, C) . DJ-1 knockdown markedly inhibited FcεRI-mediated degranulation in HuMCs both in the absence (Fig 2, B , blue lines) and presence (Fig 2, B , red lines) of stem cell factor (SCF), which enhances FcεRI-dependent degranulation.
14 Degranulation induced by thapsigargin, which causes cytosolic Ca 21 increases by inhibiting Ca 21 uptake into intracellular stores, or by G protein-coupled receptor agonists (Fig 2, C) , was not affected by loss of DJ-1 (Fig 2, C) , which is consistent with specificity on FcεRI signaling. FcεRI-mediated release of prostaglandin D 2 (PGD 2 ) and GM-CSF (Fig 2, D and F) , but not thapsigargininduced PGD 2 release (Fig 2, E) , was also substantially reduced with DJ-1 knockdown compared with nontarget shRNAs. DJ-1 knockdown had similar effects on FcεRI-dependent responses in LAD2 MCs (see Fig E3, A-D, in this article's Online Repository at www.jacionline.org).
Pretreatment of HuMCs with the general ROS scavenger 2,2,6,6-tetramethylpiperidin-1-oxyl (TEMPO) before MC stimulation reversed the augmented intracellular ROS levels in DJ-1 knockdown cells (Fig 3, A) but did not restore the inhibition of degranulation (Fig 3, B) or PGD 2 (Fig 3, C) and GM-CSF (Fig  3, D) secretion caused by DJ-1 shRNA silencing. Similarly, the antioxidant TEMPO did not restore FcεRI-dependent responses in LAD2 cells (see Fig E3, E) . Higher concentrations of TEMPO (300 mmol/L) did not have significantly greater effects on ROS Fig 2, B) or the indicated concentrations of thapsigargin, complement component 3a (C3a), and Compound 48/80 (Fig 2, C) . In Fig 2, B, IgE-sensitized HuMCs were stimulated with various concentrations of SA in media with (red lines) or without (blue line) 100 ng/mL SCF. Degranulation was measured as b-hexosaminidase activity released into the extracellular medium and expressed as a percentage of total cellular b-hexosaminidase activity. D and E, Effect of DJ-1 knockdown in production of PGD 2 secreted into culture medium induced by the indicated concentrations of SA (Fig 2, D) or thapsigargin (Fig 2, E) 6 hours after stimulation. PGD 2 production was determined by using ELISA. F, Effect of DJ-1 knockdown in production of the cytokine GM-CSF induced by SA. HuMCs were stimulated for 6 hours, and amounts of GM-CSF released into the media were determined by using ELISA. All values are means 6 SEMs from 3 independent experiments. NT, Nontarget. **P < .01. levels than 100 mmol/L TEMPO (Fig 3, A , and see Fig E3, F) but induced 20% cell death, and thus this concentration was not used in the study. The results with concentrations of TEMPO that markedly reduce ROS levels (although not totally) are consistent with the conclusion that the defect in FcεRI-induced mediator release in DJ-1 knockdown HuMCs is largely (about 40%) unrelated to increased intracellular ROS levels because of the loss of DJ-1 antioxidant activity.
Increased ROS caused by knockdown of DJ-1 results in enhanced activity of SHP-2 but not SHP-1 DJ-1 has been reported to alter function of the tyrosines SHP-1 and SHP-2 in mouse bone marrow-derived mast cells (mBMMCs) and to negatively regulate FcεRI-induced activation. 6 In marked contrast, in human LAD2 cells FcεRI-induced activation of SHP-1 was not affected by DJ-1 knockdown (Fig 4, A) . Furthermore, in LAD2 cells pretreatment with TEMPO (Fig 4, B) or incubation of SHP-1 immunoprecipitates with H 2 O 2 did not alter activation of SHP-1 (Fig 4, C) . This contrasts with mBMMCs, in which inhibition of SHP-1 activity by DJ-1 deficiency was reversed by the antioxidant TEMPO and was concluded to be the main mechanism involved in the hyperreactive phenotype found in DJ-1-deficient mBMMCs. 6 In contrast, SHP-2 activation was enhanced in DJ-1 knockdown human LAD2 MCs (Fig 4, D) , an effect shared with DJ-1-deficient BMMCs. 6 The enhanced activation of SHP-2 was fully restored by treatment with TEMPO (Fig 4, E) , indicating this effect is ROS mediated. Further confirming this conclusion, H 2 O 2 induced a dose-dependent increase in SHP-2 activity in immunoprecipitates after FcεRI ligation (Fig 4, F) . These results indicate that although the role of DJ-1 as a negative regulator of SHP-2 activation is conserved in human and mouse MCs, DJ-1 plays no role in the regulation of SHP-1 in human MCs. Therefore the antioxidant (Fig 3, B) , PGD 2 (Fig 3, C) , and GM-CSF (Fig 3, D) secretion in HuMCs transduced with either lentiviral DJ-1 shRNA or nontarget shRNA control. IgE-sensitized cells were pretreated with TEMPO for 10 minutes and then stimulated with SA. Degranulation (Fig 3, B) was measured as a percentage of b-hexosaminidase released into the media 30 minutes after stimulation, and amounts of PGD 2 (Fig 3, C) and GM-CSF (Fig 3, D) secreted into culture medium were determined 6 hours after activation. All values are means 6 SEMs from 3 independent experiments. *P < .05 and **P < .01.
component of DJ-1 function in human MCs is restricted to the control of SHP-2, and this, together with the lack of effect on SHP-1, might help explain the opposing mediator release effects between human and mouse MCs.
Knockdown of DJ-1 inhibits FcεRI-induced Lyn activation mostly independently of its effects on ROS
Because nonoxidized DJ-1 translocated to lipid rafts early after ligation of FcεRI and activation of SFKs, including Lyn, Fyn, and Fgr, are the most receptor-proximal events, 3, 4, [15] [16] [17] we explored the possibility that reduced DJ-1 expression affects their activity. Activation of Lyn kinase was significantly impaired in DJ-1-silenced LAD2 cells (Fig 5, A, left panel) . However, the activities of Fyn and Fgr (Fig 5, A, middle and right panels) were not affected. Inhibition of Lyn by DJ-1 knockdown was mostly independent of its regulation of ROS levels because it was only partially reversed by treatment with TEMPO (Fig 5, B) . In agreement, addition of H 2 O 2 to immunoprecipitated Lyn only mildly reduced its Lyn tyrosine kinase activity (Fig 5, C) . As in LAD2 cells, DJ-1 knockdown also impaired activation of Lyn in primary HuMCs and showed little dependency on ROS levels (see Fig E4 in this article's Online Repository at www.jacionline.org). These results also contrasted with the effect of DJ-1 deficiency or knockdown in mBMMCs, 6 where Lyn was not found to be affected, and this suggests that DJ-1 is an important contributor to Lyn activation in HuMCs but not mBMMCs, an effect that seems in general unrelated to DJ-1 antioxidant activity.
DJ-1 is critical for activation of Syk and Sykdependent phosphorylation events independently of its effects on ROS
Syk activation by Lyn is critical for early signaling events mediated by FcεRI. 18 Consistent with the effect on Lyn, Syk activity in immunoprecipitates was reduced significantly by DJ-1 knockdown in LAD2 MCs after FcεRI stimulation (Fig 6, A) , and this effect was only partially restored by treatment with TEMPO (Fig 6, B) . In agreement with the reduction in Syk activity, we observed reduced phosphorylation of Syk in tyrosines 525/526 and 352 (Fig 6, C, upper panel) , which was minimally reversed by TEMPO (Fig 6, C, lower panel) . Furthermore, DJ-1 knockdown also reduced substantially phosphorylation of (Fig 4, A) and SHP-2 (Fig 4, D) were immunoprecipitated from cell lysates, and their phosphatase activities were measured as the amount of free phosphate released from a synthetic phosphopeptide in 30 minutes. B and E, Effect of ROS removal by TEMPO in changes in SHP-1 (Fig 4, B) and SHP-2 (Fig 4, E) activity caused by DJ-1 knockdown. LAD2 cells were pretreated with 100 mmol/L TEMPO for 10 minutes before SA stimulation, and phosphatase activities were determined as in Fig 4, A and D. C and F, Effect of incubation with H 2 O 2 for 20 minutes on SHP-1 (Fig 4,  C) and SHP-2 (Fig 4, F) activities from immunoprecipitates of nonstimulated (NS) and SA-stimulated LAD2 cells. All values are means 6 SEMs from 3 independent experiments. *P < .05.
Syk-dependent targets, including the adaptor linker for activation of T cells (LAT) and the downstream phosphorylation of phospholipase C (PLC) g1, c-Jun N-terminal kinase (JNK), and extracellular signal-regulated kinase (ERK; Fig 6, D) . However, in agreement with the lack of effect on Fyn activity, Akt phosphorylation, which is downstream of Fyn activation, 16 was not affected significantly. Of note, only a small fraction of Lyn is needed to initiate signaling early after FcεRI engagement, [19] [20] [21] and thus increased Lyn activity might not be readily detectable by means of immunoprecipitation and in vitro kinase assays until later because receptor clusters and signaling complexes enriched in Lyn become enlarged (Fig 5, A) . 6, [19] [20] [21] [22] Collectively, data are consistent with an essential role for DJ-1 in propagation of FcεRI-mediated Lyn-Syk signaling and human MC functions through mechanisms that fundamentally differ from its effects on mBMMCs.
Nonoxidized DJ-1 is required for proper phosphorylation and activation of Lyn in lipid rafts
Because DJ-1 was rapidly translocated to the plasma membrane, where Lyn triggers signaling after FcεRI engagement, we investigated whether Lyn and DJ-1 colocalize and associate after stimulation. We detected DJ-1 in immune complexes with Lyn within 3 minutes of FcεRI cross-linking in both primary HuMCs (Fig 7, A) and LAD2 MCs (Fig 7, B) , which is consistent with the finding that DJ-1 is critical for degranulation, which occurs within 2 to 3 minutes. However, the association of DJ-1 and Lyn was maximal at 7 minutes and remained so for up to 15 minutes (Fig  7, A and B, upper panels) . The persistence of the DJ-1/Lyn association after cessation of degranulation suggests roles for DJ-1 in other responses, such as cytokine and PGD 2 release, which are late MC responses. Confocal microscopic analysis confirmed the redistribution of a portion of DJ-1 to the plasma membrane and colocalization with Lyn early after stimulation (Fig 7, A and B, lower panels).
Because Lyn is enriched in lipid rafts after MC stimulation, an environment important for Lyn-mediated phosphorylation of FcεRI, 3 we suspected that DJ-1 can also relocalize to these rafts, as described in astrocytes after LPS activation. 23 Fractionation studies indicated that a substantial portion of DJ-1 translocated from the cytoplasm fractions (fractions 8-11) into lipid rafts (fractions 4-6; as defined by the marker protein flotillin-1 and Lyn), thus colocalizing with Lyn after stimulation (Fig 7, C) . Consistent with the confocal images shown in Fig 1, C , the majority of DJ-1 that translocated into lipid raft fractions was not oxidized (Fig 7, C) . Furthermore, DJ-1 was detected in immune complexes with Lyn only in detergent-insoluble fractions (lipid rafts) after MC stimulation but not in detergent-soluble fractions (Fig 7, D) , and the immunoprecipitated DJ-1 associating with Lyn in these fractions was not oxidized in Cys106 (Fig 7, D) .
The association of Lyn with DJ-1 in lipid rafts after FcεRI engagement did not appear to be required for the translocation of Lyn into these domains because silencing of DJ-1 did not prevent enrichment of Lyn in lipid rafts (Fig 7, E) . However, it markedly inhibited FcεRI-mediated Lyn phosphorylation (Fig 7, E) , indicating that DJ-1 facilitates Lyn activation.
Human nonoxidized DJ-1 directly interacts with human Lyn
Because DJ-1 is reported to directly alter the activity of kinases and tyrosine kinases, [24] [25] [26] we next determined whether recombinant DJ-1 could induce Lyn activation in vitro. As shown in Fig 8, A, recombinant DJ-1 induced a dose-dependent increase in Lyn activity in Lyn immunoprecipitates from resting LAD2 cells (Fig 8, A, black bars) . However, this induction was not observed when DJ-1 was oxidized previously with H 2 O 2 (Fig 8,  A, red bars) , which, together with the observation that oxidized DJ-1 was not present in the plasma membrane or lipid rafts early after FcεRI engagement, indicates that the effect of DJ-1 on Lyn activity is independent of its antioxidant activity.
To test whether Lyn and DJ-1 interact directly, we performed dot blots with recombinant DJ-1 and recombinant tyrosine kinases. Increasing concentrations of either purified recombinant Lyn (Fig 8, B) or DJ-1 (Fig 8, C, left panel) immobilized in nitrocellulose showed immunoreactive dots after incubation with DJ-1 (Fig 8, B) or Lyn (Fig 8, C, left panel) . In contrast, no immunoreactive dots were observed when either recombinant Fyn or Syk was used (Fig 8, B and C, left panel) . Spotted recombinant proteins immunoreacting to their corresponding antibodies are shown in Fig 8, C (right panel) , as positive controls.
Furthermore, human recombinant oxidized DJ-1 did not show positive interactions, indicating that only nonoxidized DJ-1 is able to interact with Lyn (Fig 8, D) . Dot blot assays also indicated that mouse recombinant DJ-1 did not interact with mouse Lyn (see Fig E5, A, in this article's Online Repository at www. jacionline.org), which is in agreement with the lack of effect of DJ-1 on Lyn activity in mBMMCs. Furthermore, this interaction appears to be specific between the human homologs because no immunoreactive dots were observed between mouse DJ-1/ human Lyn or human DJ-1/mouse Lyn (see Fig E5, B and C) .
Collectively, these results demonstrate a direct interaction between Lyn and nonoxidized DJ-1 that enhances the Lyn activity and appears unique to the human proteins.
DISCUSSION
MCs play a critical role in allergic disorders mainly through activation of FcεRI expressed on the MC surface. When the IgE-FcεRI complex is aggregated by multivalent antigen, the open active conformation of the SFK Lyn is favored, causing autophosphorylation of Lyn and transphosphorylation of tyrosine residues in the b and g subunits of adjacent receptors. The latter phosphorylation creates docking sites for recruitment of the tyrosine kinase Syk. Syk phosphorylation by Lyn and consequent activation amplifies signaling cascades that result ultimately in the release of vasoactive and inflammatory mediators from the MCs. [3] [4] [5] However, how exactly Lyn initiates these events in human MCs is not entirely clear. Here we demonstrate that direct binding of Lyn to DJ-1 in the plasma membrane is a required step for full Lyn kinase activation, transphosphorylation of the g subunits of FcεRI, and consequent responses in human MCs. This is a first report showing that (Fig 7, A) and LAD2 cells (Fig 7, B) were stimulated with 100 ng/mL streptavidin (SA) for 0, 3, 7, and 15 minutes, and Lyn was immunoprecipitated (upper panels). The presence of DJ-1 in the immunoprecipitates was demonstrated by using Western blotting. Confocal images show localization of DJ-1 (in green) and Lyn (in red) before and after SA stimulation of HuMCs (Fig 7, A) and LAD2 cells (Fig 7, B) . C, Distribution of Lyn and DJ-1 in sucrose density gradient centrifugation fractions from nonstimulated (NS) or SAstimulated LAD2 cell lysates. D, Lyn was immunoprecipitated from 1% Triton X-100 soluble and insoluble fractions of IgE-sensitized LAD2 cells stimulated or not with 100 ng/mL SA for 7 minutes, and the presence of DJ-1 or oxidized DJ-1 was determined by using Western blotting. E, LAD2 cells transduced with lentiviral DJ-1 shRNA or nontarget (NT) shRNA were stimulated with 100 ng/mL SA for 7 minutes. Lyn was immunoprecipitated from Triton X-100 soluble and insoluble fractions and DJ-1 or Lyn localization, and Lyn phosphorylation was determined by using Western blotting. Quantification of phospho-Lyn and Lyn is shown. Values are means 6 SEMs from 3 independent experiments. **P < .01. IP, Immunoprecipitation; n.s., not significant. DJ-1, through mechanisms partially independent of its action as an ROS scavenger, is critical for the organization of early events in human MC signaling.
Interest in understanding the biochemical and functional properties of DJ-1 (also known as PARK7) has been fueled by the association of DJ-1 mutations with familial early-onset Parkinson disease 27 and by altered levels in patients with diseases such as cancer, stroke, dermatitis and mastocytosis. 6, 7, 28, 29 A well-established function of DJ-1 is to protect cells from oxidative damage, partly by undergoing self-oxidation and thus reducing ROS levels, [30] [31] [32] although other functions for DJ-1 independent of this feature have also been described. 24, 25, 33, 34 We confirmed that FcεRI engagement induced ROS generation in HuMCs 12 and found that selfoxidation of DJ-1 30 minutes after activation occurred concomitantly with a decrease in ROS levels, which is consistent with an antioxidant role for DJ-1. Furthermore, our study reveals a requirement of DJ-1 for degranulation, cytokine, and eicosanoid responses in HuMCs that appeared to be greatly independent of its antioxidant activity because treatment with an antioxidant only restored by 20% the diminished responses caused by DJ-1 silencing. This is consistent with reports indicating that ROS generation has little effect on FcεRI-mediated MC responses. 35 Thus the data support ROS-dependent and ROSindependent roles for DJ-1 in HuMC responses. We provide evidence that a consequence of DJ-1 antioxidant activity is to restrict SHP-2 activation by removing excess ROS levels, which normally enhance SHP-2 phosphatase activity, as was observed in mBMMCs. 6 However, unlike in mBMMCs, DJ-1 had no effect on SHP-1 activity. Restricted SHP-2 activity would result in diminished Syk dephosphorylation and thus sustained Syk activation. Values are means 6 SEMs from 3 independent experiments. *P < .05. B and C, Human recombinant Lyn, Fyn, Syk, and DJ-1 were immobilized on a nitrocellulose membrane and incubated with a solution of 100 ng/ mL human recombinant DJ-1 (Fig 8, B) or human recombinant Lyn (Fig 8, C) . After washing, positive interactions were revealed by using antibodies against DJ-1 (Fig 8, B) or anti-Lyn (Fig 8, C) . Fig 8, C , right panel, Positive controls for recognition of dotted proteins to the corresponding antibodies. D, Dot blots demonstrating that only nonoxidized human recombinant DJ-1 (h R DJ-1) interacts with human recombinant Lyn. Blots are representative of 3 experiments. E, Model summarizing the findings. After activation of FcεRI, nonoxidized DJ-1 is translocated to lipid rafts, where it interacts with Lyn, facilitating its activity and downstream signaling. In addition, at later times after FcεRI engagement, DJ-1 has a positive effect on MC signaling, acting as an antioxidant protein that reduces ROS levels and thus limiting SHP-2 activation and enhancing Lyn activity, both of which favor Syk activation and MC responses. MAPKs, Mitogenactivated protein kinases.
In addition, silencing of DJ-1 expression markedly reduced Lyn activity in HuMCs through a mechanism unrelated to its ROS scavenger activity, as was true for mediator release, and involved a direct and specific association with Lyn. DJ-1 did not associate similarly with Syk or the SFK Fyn, and Akt signaling downstream of Fyn was unaffected by the absence of DJ-1. DJ-1 has been reported to alter the activity of certain receptors and signaling proteins in part through direct association 36, 37 and in some instances through mechanisms that are not yet well understood. 24, 25, 33, 38 Based on our findings, we propose a unique dual function for DJ-1 in FcεRI-activated human MCs sequentially regulating Lyn and Syk pathways: initially when DJ-1 is not oxidized by directly facilitating Lyn activation and later as it becomes oxidized by reducing ROS levels and SHP-2 activity, thus potentially alleviating SHP-2 repression of Syk activity (Fig 8, E) .
We provide insights into how and where DJ-1 exerts its regulation of Lyn activation. Similar to other cells, 39, 40 in nonstimulated HuMCs DJ-1 appeared localized intracellularly, but shortly and transiently after activation, a fraction of nonoxidized DJ-1 translocated to lipid rafts. Lipid rafts are plasma membrane microdomains enriched in cholesterol, glycosphingolipids, and sphingolipids, 41, 42 which are believed to generally function as focal points for consolidation of FcεRI signaling components. Lyn and DJ-1 not only colocalized but also formed distinct Lyn/ DJ-1 immune complexes in these domains in response to FcεRI ligation. Formation of such complexes did not require adaptor proteins because purified recombinant DJ-1 directly bound recombinant Lyn in vitro and resulted in enhanced Lyn activity. Although the precise mechanisms for the effect on Lyn activity are not entirely clear, they appear to be partly independent of its antioxidant function. It is unlikely that DJ-1 prevents interactions with C-terminal Src kinase (Csk) binding protein/Csk complexes, a feedback loop that keeps Lyn in an inactive state through phosphorylation of Lyn in Tyr507, 43 because DJ-1 deficiency did not alter Lyn phosphorylation in Tyr507 or the phosphorylation and levels of Csk binding protein that coimmunoprecipitated with Lyn (see Fig E6, A, in this article's Online Repository at www. jacionline.org). Nevertheless, DJ-1 knockdown blunted total phosphorylation of Lyn and its association with Fcg subunits (see Fig E6, A) , and recombinant DJ-1 was sufficient by itself to enhance Lyn kinase activity in Lyn immunoprecipitates from unstimulated MCs and of recombinant Lyn in vitro (Fig 8, A , and see Fig E6, B) to suggest that a consequence of Lyn/DJ-1 interaction might be to promote the open and active conformation of Lyn.
Active conformation of Lyn is usually favored by binding of the Lyn SH2 and SH3 domains to phosphotyrosine-containing sequences and proline-rich motifs, respectively.
44,45 DJ-1 does not contain proline-rich motifs, but it was phosphorylated on tyrosine after antigen stimulation (see Fig E6, C) . The fact that purified recombinant DJ-1 and Lyn interacted in the absence of ATP in our studies suggests that DJ-1 phosphorylation is not necessary for binding but might stabilize active conformation of Lyn. However, it appears that a nonoxidized Cys106 is required for interaction and enhancement of Lyn activity. The interaction between human Lyn and DJ-1 is also species specific in that it was not observed between the 2 murine proteins or between human and murine homologs, which suggests an acquired function for DJ-1 in human subjects despite the overall sequence homology between species. This adds a cautionary note in translating mouse data to human subjects with respect to MC activation mechanisms.
Collectively, our results shed new light on the regulation of human MC responses after IgE receptor engagement by identifying DJ-1 as an unsuspected player in Lyn activation. This function of DJ-1 requires nonoxidized cysteine residues, as well as translocation of DJ-1 to lipid rafts and direct interaction with Lyn, which facilitates its kinase activity and initiation of signaling cascades. Thus further characterization of DJ-1/Lyn interaction might open new avenues of therapeutic modalities in patients with MC-derived diseases. The finding of DJ-1 as an essential regulator of Lyn might also be relevant for other immunoglobulin receptors and/or human immune cells in which Lyn function is critical.
Key messages
d Ligation of FcεRI in human MCs induces the early translocation of nonoxidized DJ-1 to lipid rafts, where it interacts with Lyn, enabling its full activation, downstream signaling, and MC responses.
d After FcεRI activation, the ability of DJ-1 to become oxidized quenches ROS levels and reduces the activity of the phosphatase SHP-2, which permits further Sykmediated signaling.
d Further characterization of the interaction of DJ-1 with Lyn could form the basis for alternative treatments in allergic subjects.
METHODS HuMCs
Primary HuMCs were derived from CD34 1 peripheral blood progenitors isolated from healthy volunteers after achieving informed consent under a protocol (NCT00001756) approved by the Institutional Review Board of the National Institute of Allergy and Infectious Diseases (National Institutes of Health). CD34 1 cells were cultured in StemPro-34 SFM Complete Medium (Invitrogen, Grand Island, NY), L-glutamine (2 mmol/L), penicillin (100 IU/mL), streptomycin (100 mg/mL), 100 ng/mL human recombinant SCF, and 100 ng/mL human recombinant IL-6 (R&D Systems), except for the initial week of culture, when 30 ng/mL human recombinant IL-3 (PeproTech, Rocky Hill, NJ) was also present, as previously described. E1 Cells were used for experiments by 6 to 8 weeks, when 99% of cells were identifiable as FcεRI Complete Medium supplemented with 100 ng/mL human recombinant SCF, L-glutamine (2 mmol/L), penicillin (100 IU/mL), and streptomycin (100 mg/mL), as previously described. E2 For activation, HuMCs and LAD2 cells were sensitized overnight with biotinylated IgE (0.1 mg/mL) and washed, and the IgE-bound FcεRI was cross-linked with 100 ng/mL streptavidin for the indicated times.
Antibodies and recombinant proteins
Antibodies against DJ-1 (sc-27006) and Lyn (sc-15) were from Santa Cruz Biotechnology (Dallas, Tex) and used at a dilution of 1:1000 for Western blotting. Antibodies against oxidized DJ-1 (Cys106; MABN1773, diluted to 1:200) and phosphotyrosine (pY) residues (05-321, diluted to 1:1000) were from EMD Millipore (Billerica, Mass). Anti-phospho-Syk (Tyr525/526; no. 2711), anti-phospho-LAT (Tyr191; no. 3584), anti-phospho-Akt (Thr308; no. 9275), anti-phospho-SAPK/JNK (Thr183/Tyr185; no. 9251), anti-phosphop44/42 MAPK (ERK1/2; Thr202/Tyr204; no. 9101), anti-phospho-PLCg1 (Y783; no. 2821), and anti-flotillin-1 (no. 3253) antibodies were from Cell Signaling Technology (Beverly, Mass) and diluted to 1:2000 for Western blotting, except for anti-flotillin, which was diluted to 1:1000. Anti-b-actin (A5316), which was used as a loading control at 1:5000 dilution, was purchased from Sigma-Aldrich (St Louis, Mo). For immunoprecipitation, anti-Lyn (sc-7274), anti-Fyn (sc28791), anti-Syk (sc-929), and anti-SHP-1 (sc-287) antibodies were from Santa Cruz Biotechnology; anti-Fgr (sc-17) was from Cell Signaling Technology, and anti-SHP2 (ab32083) was from Abcam (Cambridge, Mass). For confocal microscopy, anti-Lyn antibody (628102; diluted to 1:1000) was purchased from BioLegend (San Diego, Calif); anti-DJ-1 (sc-32874 diluted to 1:1000) was from Santa Cruz Biotechnology, and anti-oxDJ-1 (Cys106; HCA024, diluted to 1:500) was from Bio-Rad Laboratories (formerly AbD Serotec, Raleigh, NC). Recombinant human Lyn, Fyn, Syk and recombinant mouse Lyn proteins for dot blots were from EMD Millipore. Human DJ-1 recombinant protein was from AnaSpec (San Jose, Calif), and mouse DJ-1, Fyn, Syk recombinant proteins were from MyBioSource (San Diego, Calif).
Knockdown of DJ-1 by shRNA
Nontarget control vector (SHC002) or DJ-1-targeted shRNAs (TRCN0000004921) were purchased from Sigma-Aldrich. This DJ-1 shRNA construct was selected among other available constructs (TRCN0000004918, TRCN0000004919, and TRCN0000004920) for its consistency in silencing DJ-1 in HuMCs and LAD2 cells, although they all reduced DJ-1 expression (Fig E2) . The Mission Lentiviral Packaging Mix (Sigma-Aldrich) and the pLKO1 vectors with sh-DJ-1 or control shRNA (3.4 mg) were cotransfected into 293T cells (4 3 10 6 cells) with FuGENE6 Transfection Reagent (Roche, Indianapolis, Ind) in Opti-MEM as previously described. E3 The viral particles in the media were collected and 0.5 to 1.0 mL of this volume was transferred to a T25 culture flask containing 1 to 2 3 10 6 HuMC or LAD2 in 10 mL of complete StemPro Medium. Two days after transduction, cells were placed in fresh complete media for 2 additional days. Transduced cells were selected in media containing 0.2 mg/mL puromycin (Sigma-Aldrich) for 5 days. After a recovery period of 2 days, cells were used for experiments. Most experiments were also repeated in cells by using DJ-1 shRNA knockdown 3 to 4 days after transduction without puromycin selection, with very similar results (not shown).
Measurement of ROS and DJ-1 levels
Intracellular ROS levels were measured with the OxiSelect Intracellular ROS Assay kit (Cell Biolabs). HuMCs (2 3 10 5 cells/1.5 mL) and LAD2 cells (2 3 10 5 cells/1.5 mL) were sensitized overnight with biotinylated IgE (0.1 mg/mL) and washed, and the IgE-bound FcεRI was cross-linked with 100 ng/mL streptavidin for various time periods. Cells were incubated at 378C with 29, 79-dichlorofluorescin diacetate (20 mmol/L) for the last 15 minutes of stimulation with streptavidin, and ROS was quantified, as previously described. E4 For cell imaging of intracellular ROS, dichlorofluoresceinloaded cells treated as above were fixed in 4% formaldehyde for 10 minutes.
In some experiments cells were pretreated with the antioxidant TEMPO (30 mmol/L) for 10 minutes before stimulation with streptavidin. Confocal images were obtained in a Leica SP5 X confocal laser scanning microscope with an Apochromat 603 objective (Leica Microsystems).
For DJ-1 measurements, HuMCs or LAD2 cells (5 3 10 5 cells/1.0 mL) were sensitized with IgE and stimulated with streptavidin, as described above. Aliquots of supernatants were taken at the indicated times, and DJ-1 levels were measured by using ELISA (R&D Systems). Alternatively, supernatants were concentrated to 10 mL by using ultrafiltration (Amicon Ultra-4 Centrifugal Filter Units; 10 kDa; EMD Millipore), and the proteins were solubilized with 23 SDS sample buffer and separated by means of SDS-PAGE with 4-12% gels. For detection of intracellular and oxidized DJ-1, cells were lysed in 200 mL of lysis buffer, and 10 mL per sample was used for Western blot determinations.
Measurement of DJ-1 mRNA
Total cellular RNA was extracted from 5 3 10 5 cells by using an RNeasy Plus Mini Kit (Qiagen, Valencia, Calif). A 1-mg aliquot of RNA was reverse transcribed by using SuperScript III reverse transcriptase (Invitrogen Life Technologies, Carlsbad, Calif). Quantitative PCR was executed in 96-well plates by using the ABI Prism 7500 Real Time PCR System (Foster City, Calif) and TaqMan gene expression assays for DJ-1 (AIVI5HL), and glyceraldehyde-3-phosphate dehydrogenase as the endogenous control gene (Assay ID: Hs99999905_m1; Life Technologies, Grand Island, NY) was used for normalization. For Western blot analysis, equal amounts of proteins (20 mg) were separated by using SDS-PAGE with 4-12% gels and then transferred onto nitrocellulose membranes. The membranes were blocked with 5% BSA in Tris-buffered saline for 1 hour and then incubated with specific primary antibodies overnight at 48C. Immunoreactive bands were detected by using infrared dye-conjugated secondary antibodies (1:20,000; LI-COR Biosciences, Lincoln, Neb) imaged and quantified with an Odyssey imager (LI-COR Biosciences).
Immunoprecipitation and Western blot analysis
Measurement of phosphatase activity of SHP-1 and SHP-2 SHP-1 and SHP-2 were immunoprecipitated from streptavidin-stimulated LAD2 cells in HEPES-BSA buffer for 7 minutes. SHP-1 and SHP-2 phosphatase activities in the immunoprecipitates were measured with a DuoSet IC Phosphatase Assay (R&D Systems) by determining the amount of free phosphate after incubation with a synthetic phosphopeptide substrate for 30 minutes, according to the manufacturer's protocol.
In vitro kinase assay
Immunoprecipitates of Lyn, Fyn, Fgr, or Syk from 1-mg whole-cell lysates were assayed for kinase activity by using the ELISA-based Universal Tyrosine Kinase Assay Kit (Gen Way), according to the manufacturer's instructions. One unit of tyrosine kinase represents incorporation of 1 pmol of phosphate into the substrate (a p34cdc2 peptide fragment of about 6-20 amino acids) per minute.
Dot blots
Recombinant Lyn, Fyn, and Syk were dotted on nitrocellulose membranes (0.45-mm pore size; Invitrogen), and the membranes were blocked with TBSTween 20 (150 mmol/L NaCl, 25 mmol/L Tris [pH 7.5], and 0.05% Tween 20) containing 5% BSA for 1 hour at room temperature. Recombinant DJ-1 was diluted in TBS-Tween 20 plus 0.05% BSA and incubated with the membrane for 1 hour to allow for recognition of the spotted proteins. After washing 3 times in TBS-Tween 20 plus 0.1% milk, the membrane was incubated with anti-DJ-1 antibody overnight at 48C. Membranes were detected by using the LI-COR Odyssey with IR-conjugated secondary antibodies. Oxidized recombinant DJ-1 was prepared by incubating recombinant DJ-1 with H 2 O 2 for 30 minutes and then removing H 2 O 2 by using ultrafiltration (Amicon Ultra-4 Centrifugal Filter Units; 10 kDa; EMD Millipore).
Confocal microscopy
Nonstimulated and streptavidin-stimulated HuMCs and LAD2 cells were seeded in 8-well Lab-Tek chamber slides at a cell density of 3 3 10 4 cells/well and centrifuged at 600 rpm for 5 minutes. After washing with PBS, HuMCs or LAD2 cells were fixed with 4% formaldehyde in PBS for 10 minutes, washed with PBS, and permeabilized with 0.1% Triton X-100 for 10 minutes. 
Isolation of detergent-resistant membranes
LAD2 cells treated as indicated in the figure legends were washed twice with ice-cold PBS and lysed in ice-cold PBS containing 1% Triton X-100 and protease inhibitors (1 mmol/L phenylmethylsulfonyl fluoride, 1 mg/mL leupeptin, 1 mg/mL aprotinin, and 1 mmol/L EDTA) for 20 minutes. Lysates were centrifuged at 16,600g for 10 minutes at 48C, and the corresponding supernatants were used as soluble fractions. Pellets were washed with ice-cold PBS buffer, solubilized with 13 sample buffer, and used as an insoluble fraction.
For sucrose density gradient centrifugation fractionation analysis, LAD2 cells (2.0 3 10 7 ) were washed twice with ice-cold PBS and lysed in 2 mL of TNE buffer (50 mmol/L Tris-HCl [pH 7.4], 150 mmol/L NaCl, 1 mmol/L EDTA, 50 mmol/L NaF, 2.5 mmol/L sodium pyrophosphate, 1 mmol/L sodium orthovanadate, 1 mmol/L phenylmethylsulfonyl fluoride, 1 mg/mL leupeptin, and 1 mg/mL aprotinin) containing 0.5% Brij 58 for 30 minutes on ice. Lysates were mixed with an equal volume of 80% (wt/vol) sucrose in TNE buffer. A sucrose gradient was prepared by sequential addition of 1.5 mL of 80% sucrose, 2 mL of a 1:1 mixture of 80% sucrose and cell lysate, 4 mL of 35% sucrose, and finally 4 mL of 5% sucrose, which was processed by means of ultracentrifugation at 270,000g for 18 hours at 48C. One-milliliter fractions (for a total of 12 fractions) were collected from the top to the bottom of the gradient for Western blot analysis.
Statistical analysis
Data were expressed as means 6 SEMs from 3 or more independent experiments. One-way ANOVA was used to determine statistically significant differences between groups by using Prism 6 software (GraphPad Software). (Fig E2, A) and mRNA expression (Fig E2, B) Fig E3, A) or the indicated concentrations of thapsigargin, complement component 3a (C3a), and Compound 48/80 (Fig E3, B) . Fig E3, A, IgE-sensitized LAD2 cells were stimulated with various concentrations of SA in media with (red lines) or without (blue line) 100 ng/mL SCF. Degranulation was measured as b-hexosaminidase activity released into the extracellular medium after 30 minutes of stimulation and expressed as a percentage of the total cellular b-hexosaminidase activity. C and D, Effect of DJ-1 knockdown (open circles) in production of PGD 2 induced by SA (Fig E3, C, left panel) or by thapsigargin (Fig E3, C, right panel) and in production of the cytokine GM-CSF (Fig E3, D) induced by SA in LAD2 cells. E, IgE-sensitized LAD2 cells were pretreated with 30 or 100 mmol/L of the antioxidant TEMPO for 10 minutes and then incubated with or without the indicated concentrations of SA. The extent of degranulation after 30 minutes (left panels) and release of PGD 2 (middle panels) and GM-CSF (right panels) after 6 hours were determined as in Fig E3, A-D . F, Representative confocal microscopic images showing intracellular ROS levels in control and DJ-1 knockdown LAD2 cells pretreated or not with 30 mmol/L TEMPO for 10 minutes before SA stimulation (100 ng/mL) for 30 minutes. Right panels show determinations of ROS levels in LAD2 cells after pretreatment with 30, 100, and 300 mmol/L TEMPO 10 minutes before stimulation with the indicated concentrations of SA. All values are means 6 SEMs from 3 independent experiments. NT, Nontarget. *P < .05 and **P < .01.
FIG E4
. DJ-1 knockdown reduced Lyn activity in primary human MCs, and this effect is only partially restored by increased ROS. A, HuMCs transduced with lentiviral DJ-1 shRNA or nontarget (NT) shRNA were sensitized with IgE and stimulated with 100 ng/mL streptavidin (SA) for the indicated times. B, Control or DJ-1 shRNA-silenced HuMCs were stimulated with SA for 10 minutes in the absence and presence of 30 mmol/L (left panel) or 100 mmol/L (right panel) TEMPO for 10 minutes before SA stimulation. Lyn was immunoprecipitated from the indicated cell lysates, and Lyn activity was measured with an ELISA-based Tyrosine Kinase Assay Kit. All values are means 6 SEMs from 3 independent experiments. *P < .05 and **P < .01.
FIG E5.
Mouse DJ-1, unlike the human homologs, does not interact with Lyn. A, Recombinant mouse Lyn and recombinant mouse DJ-1 do not show direct interaction. Various amounts of mouse recombinant Lyn, Fyn, and Syk and DJ-1 were immobilized on a nitrocellulose membrane, as indicated. Membranes were incubated with a solution of mouse recombinant DJ-1 (left) or mouse recombinant Lyn (right) at a concentration of 100 mg/mL. Interaction between the dotted protein and the protein in solution were revealed by using antibodies against DJ-1 or anti-Lyn, as indicated. B and C, Dot blots demonstrating lack of interaction between mouse DJ-1 and human Lyn (Fig E5, B) or between human DJ-1 and mouse Lyn (Fig E5, C) .
